about
Nanocrystal targeting in vivo.In vitro activity of biapenem (L-627), a new carbapenem, against anaerobesThe renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphAIn vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IImipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effectsIn vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteriaBiochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).Discovery and development of new antimicrobial agents.Cloning and Characterization of a Novel Esterase from Rhodococcus sp. for Highly Enantioselective Synthesis of a Chiral Cilastatin Precursor.The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.Treatment of uncomplicated gonorrhea with single-dose imipenem-cilastatinMulticenter in vitro evaluation of SM-7338, a new carbapenem.Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infectionsAsymmetric catalysis: an enabling scienceActivity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IPharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animalsRespiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infectionsTentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenemSynthesis of labeled meropenem for the analysis of M. tuberculosis transpeptidases.β-Lactams and β-Lactamase Inhibitors: An Overview.Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases.Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.In vitro and pharmacokinetic properties of the carbapenems.In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus.Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.In vitro activity and beta-lactamase stability of a new penem, CGP 31608In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
P2860
Q24538147-DAB19E6E-1470-48BB-9658-AA1F2D8F9536Q24613554-CD61F460-C4ED-4EB1-A7AE-CA7779E9C3E1Q24676934-DE49AAC4-E7AD-409A-8703-99B34BBA5822Q24679571-5B89DC03-37FF-4E3A-B177-AC40F4C49E7FQ28260317-1F3C8E38-F086-45F5-B831-873AD1788BD9Q33761212-6490446E-1ED5-4CA9-88F0-43BA0AF9F425Q33978241-B613F027-FD26-45BB-BE5A-807513713866Q34105432-75E151B8-ADD7-40CE-AED0-84F80B724061Q34371891-36CBE7FA-97EB-4B82-B6E8-CB896CC2CB1DQ34595081-4B323FED-8E4D-44B1-AAFB-A305200361FEQ34621525-E664A97C-F3F2-4FE2-86FF-4D2FA3F07B80Q35136449-C693B3D3-A00B-447C-8C60-6BEB73C40AE5Q35138759-0DF13E10-0D46-4444-B4B1-FB6742C98D26Q35139365-72EC5354-97B2-47A8-B025-51206CB6B2FCQ35306465-29E5B8C2-54A7-43C7-AE5C-8DE1E5CCBE59Q35328263-FB192A00-5280-484D-BF86-CFC5506A0FE6Q35574628-060969EE-D792-4DFE-BEE4-0C9227CF59DDQ35648273-8CBA7587-C8C7-48BF-9B72-F4E4C3C27A2BQ35649774-C3909D23-8439-4502-BEFE-2A3D8BCB0D9FQ35678271-E09FE39E-7063-487E-B021-5B2AF8508AC9Q35809041-E505711E-88C9-4ABA-9631-3800FD367C95Q36752746-3675D444-B733-48DB-BC0B-F80BC0338F5FQ36754774-41E9B9F6-5AFD-4BF5-A3BA-BEC55CBBD627Q36894089-E898C757-A7A9-470D-9117-6620FE261BD0Q37202914-10B9036F-3F41-478F-AF47-AFFDC6653279Q37272821-1CF560F1-9372-41C1-97A5-80D528ECB397Q37281738-E554F196-01E1-4BAA-8AF2-83E03B62B6B6Q37462494-D6E2A33E-7D51-4B65-9326-F4CACE0BEC46Q38872374-D9C4FC4E-F3E3-465C-A86E-194622557157Q39471986-4C5D3503-A27B-413E-BB80-FC2DDAC1024DQ39628340-72CE18E2-826B-4E52-BC57-B5A669552B1EQ39747565-965E8878-A8E6-41AB-86D3-5A025D42801BQ39780653-801E62CA-2455-4445-A95E-5D8A84600B73Q39781719-930D9843-C6E8-43B7-8D9F-4757F42B0D90Q39785118-4C647EFC-F848-43F8-B8EA-F4A9E7639294Q39815200-D2312B46-3112-4B6E-B84F-F35672D1BAFAQ39818487-80C542C1-3593-4971-8A1C-3C7FD5E5081FQ39819588-F73EC1AB-3114-497E-8A05-3DDEEC10840CQ39827980-DAC1A642-C7F0-4A6A-8A4A-8898EBB0C36BQ39833008-C772EE86-2727-4A8C-8012-A254FEF916B0
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Thienamycin: development of imipenen-cilastatin
@ast
Thienamycin: development of imipenen-cilastatin
@en
Thienamycin: development of imipenen-cilastatin
@nl
type
label
Thienamycin: development of imipenen-cilastatin
@ast
Thienamycin: development of imipenen-cilastatin
@en
Thienamycin: development of imipenen-cilastatin
@nl
prefLabel
Thienamycin: development of imipenen-cilastatin
@ast
Thienamycin: development of imipenen-cilastatin
@en
Thienamycin: development of imipenen-cilastatin
@nl
P2093
P1476
Thienamycin: development of imipenen-cilastatin
@en
P2093
P407
P478
12 Suppl D
P577
1983-12-01T00:00:00Z